AHA Regarding the 340B Program

AHA to the Subcommittee on Oversight and Investigations Committee on Energy and Commerce regarding the 340B program.

Key Resources

Related Resources

Advancing Health Podcast
How Legal Advocacy Is Shaping the Future of Health Care
Public
Guides/Reports
More Drug Company Oversight Needed to Maintain Compliance with 340B Program Rules
Public
Issue Landing Page
The 340B Drug Pricing Program
Public
Letter/Comment
AHA Urges HHS to Reject the Effort by Several Large Drug Companies to Undermine the 340B Drug Pricing Program
Public
Action Alert
ACT NOW: Urge Your Members of Congress to Protect Medicaid and Other Crucial Programs
Member
Guides/Reports
Costs of Caring
Public